Insmed (NASDAQ: INSM) reported Q1 EPS of ($0.80), $0.08 better than the analyst estimate of ($0.88). Revenue for the quarter came in at $53.1 million versus the consensus estimate of $53.39 million.

For earnings history and earnings-related data on Insmed (INSM) click here.